Skip to main content
. Author manuscript; available in PMC: 2015 Oct 1.
Published in final edited form as: Glycoconj J. 2014 Oct;31(0):509–521. doi: 10.1007/s10719-014-9548-4

Table 2.

Histochemical analysis of TMA and tissue sectionsa

Tissue/ TMA Lowb Moderate High
Breast PNA-HRP Normal graphic file with name nihms622562t1.jpgPAIRED 13/15 (86.7%) 2/15 (13.3%) 0/15 (0%)
Tumor 2/15 (13.3%) 3/15 (20%) 10/15 (66.7%)
Tumor (All) 28/115 (24.4%) 49/115 (42.6%) 38/115 (33%)

anti T- antigen mAb Normal graphic file with name nihms622562t2.jpgPAIRED 15/15 (100%) 0/15 (0%) 0/15 (0%)
Tumor 4/15 (26.6%) 2/15 (13.3%) 9/15 (60%)
Tumor (All) 41/115 (35.7%) 43/115 (37.4%) 31/115 (27%)

Colon PNA- HRP
Tumor (All) 18/26 (69.3%) 5/26 (19.2%) 3/26 (11.5%)
anti T- antigen mAb Tumor (All) 10/18 (55.6%) 5/18 (27.8%) 3/18 (16.6%)
a

Low: Index scoring = 0–100, Moderate: Index scoring = 101–200, High: Index scoring = 201–300

b

# of patients stained in that range/ total # of patients

HHS Vulnerability Disclosure